{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:56:31Z","timestamp":1790207791862,"version":"4.1.0"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R03MH094966-01A1"],"award-info":[{"award-number":["R03MH094966-01A1"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["PSI2015-68497- R"],"award-info":[{"award-number":["PSI2015-68497- R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.pbb.2020.173035","type":"journal-article","created":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T22:26:56Z","timestamp":1599517616000},"page":"173035","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["The non-selective adenosine antagonist theophylline reverses the effects of dopamine antagonism on tremor, motor activity and effort-based decision-making"],"prefix":"10.1016","volume":"198","author":[{"given":"Marta","family":"Pardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas E.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyndsey E.","family":"Collins-Praino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Salamone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merc\u00e8","family":"Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2020.173035_bb0005","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neuropharm.2013.01.002","article-title":"Caffeine has greater potency and efficacy than theophylline to reverse the motor impairment caused by chronic but not acute interruption of striatal dopaminergic transmission in rats","volume":"70","author":"Acu\u00f1a-Lizama","year":"2013","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.pbb.2020.173035_bb0010","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s00213-005-0173-6","article-title":"A detailed behavioral analysis of the acute motor effects of caffeine in the rat: involvement of adenosine A1 and A2A receptors","volume":"183","author":"Antoniou","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2020.173035_bb0015","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neuroscience.2009.05.040","article-title":"Effects of the adenosine A2A antagonist KW 6002 (istradefylline) on pimozide-induced oral tremor and striatal c-Fos expression: comparisons with the muscarinic antagonist tropicamide","volume":"163","author":"Betz","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2020.173035_bb0020","first-page":"181","article-title":"Theophylline, adenosine receptor antagonist prevents behavioral, biochemical and neurochemical changes associated with an animal model of tardive dyskinesia","volume":"59","author":"Bishnoi","year":"2007","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.pbb.2020.173035_bb0025","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/0006-3223(88)90138-2","article-title":"Theophylline reverses haloperidol-induced catalepsy in the rat. Possible relevance to the pharmacological treatment of psychosis","volume":"24","author":"Casas","year":"1988","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2020.173035_bb0030","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.pbb.2009.11.011","article-title":"Oral tremor induced by the muscarinic agonist pilocarpine is suppressed by the adenosine A2A antagonists MSX-3 and SCH58261, but not the adenosine A1 antagonist DPCPX","volume":"94","author":"Collins","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2020.173035_bb0035","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bbr.2010.03.003","article-title":"Interactions between adenosine and dopamine receptor antagonists with different selectivity profiles: effects on locomotor activity","volume":"211","author":"Collins","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2020.173035_bb0040","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.pbb.2011.10.015","article-title":"The novel adenosine A2A antagonist Lu AA47070 reverses the motor and motivational effects produced by dopamine D2 receptor blockade","volume":"100","author":"Collins","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2020.173035_bb0045","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fnsys.2011.00049","article-title":"Pharmacological and physiological characterization of the tremulous jaw movement model of parkinsonian tremor: potential insights into the pathophysiology of tremor","volume":"5","author":"Collins-Praino","year":"2011","journal-title":"Front. Syst. Neurosci."},{"issue":"1","key":"10.1016\/j.pbb.2020.173035_bb0050","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bbr.2012.06.011","article-title":"Extracellular GABA in globus pallidus increases during the induction of oral tremor by haloperidol but not by muscarinic receptor stimulation","volume":"234","author":"Collins-Praino","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2020.173035_bb0055","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1111\/ejn.12212","article-title":"Deep brain stimulation of the subthalamic nucleus reverses oral tremor in pharmacological models of parkinsonism: interaction with the effects of adenosine A(2A) antagonism","volume":"38","author":"Collins-Praino","year":"2013","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pbb.2020.173035_bb0060","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0166-4328(03)00178-5","article-title":"The adenosine A2A antagonist KF17837 reverses the locomotor suppression and tremulous jaw movements induced by haloperidol in rats: possible relevance to parkinsonism","volume":"148","author":"Correa","year":"2004","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2020.173035_bb0065","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00213-015-4127-3","article-title":"Choosing voluntary exercise over sucrose consumption depends upon dopamine transmission: effects of haloperidol in wild type and adenosine A\u2082AKO mice","volume":"233","author":"Correa","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2020.173035_bb0070","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3389\/fpsyt.2018.00411","article-title":"Caffeine modulates food intake depending on the context that gives access to food: comparison with dopamine depletion","volume":"9","author":"Correa","year":"2018","journal-title":"Front Psychiat."},{"key":"10.1016\/j.pbb.2020.173035_bb0075","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0014-2999(97)00008-3","article-title":"Tremulous jaw movements induced by the acetylcholinesterase inhibitor tacrine: effects of antiparkinsonian drugs","volume":"322","author":"Cousins","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2020.173035_bb0080","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0031-9384(98)00021-3","article-title":"Behavioral and electromyographic characterization of the local frequency of tacrine-induced tremulous jaw movements","volume":"64","author":"Cousins","year":"1998","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.pbb.2020.173035_bb0085","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0376-8716(98)00077-5","article-title":"Caffeine\u2014an atypical drug of dependence","volume":"51","author":"Daly","year":"1998","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pbb.2020.173035_bb0090","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1017\/S1461145704004729","article-title":"The many faces of fatigue in major depressive disorder","volume":"8","author":"Demyttenaere","year":"2005","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pbb.2020.173035_bb0095","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1212\/01.WNL.0000095220.87550.F6","article-title":"Adenosine A2A receptors and depression","volume":"61","author":"El Yacoubi","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.pbb.2020.173035_bb0100","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00213-006-0554-5","article-title":"Adenosine A2A receptor antagonism reverses the effects of dopamine receptor antagonism on instrumental output and effort-related choice in the rat: implications for studies of psychomotor slowing","volume":"191","author":"Farrar","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2020.173035_bb0105","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.neuroscience.2009.12.056","article-title":"Nucleus accumbens and effort-related functions: behavioral and neural markers of the interactions between adenosine A2A and dopamine D2 receptors","volume":"166","author":"Farrar","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2020.173035_bb0110","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s002130050380","article-title":"Adenosine-dopamine interactions in the ventral striatum. Implications for the treatment of schizophrenia","volume":"133","author":"Ferr\u00e9","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2020.173035_bb0115","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1471-4159.2007.05196.x","article-title":"An update on the mechanisms of the psychostimulant effects of caffeine","volume":"105","author":"Ferr\u00e9","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pbb.2020.173035_bb0120","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1353-8020(00)00063-8","article-title":"Adenosine\/dopamine interaction: implications for the treatment of Parkinson\u2019s disease","volume":"7","author":"Ferr\u00e9","year":"2001","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.pbb.2020.173035_bb0125","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.brainresrev.2007.01.007","article-title":"Neurotransmitter receptor heteromers and their integrative role in \u2018local modules\u2019: the striatal spine module","volume":"55","author":"Ferr\u00e9","year":"2007","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.pbb.2020.173035_bb0130","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1089\/caff.2018.0017","article-title":"New developments on the adenosine mechanisms of the central effects of caffeine and their implications for neuropsychiatric disorders","volume":"8","author":"Ferr\u00e9","year":"2018","journal-title":"J. Caffeine Adenosine Res."},{"key":"10.1016\/j.pbb.2020.173035_bb5020","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0091-3057(96)00385-1","article-title":"Tremulous characteristics of the vacuous jaw movements induced by pilocarpine and ventrolateral striatal dopamine depletions","volume":"57","author":"Finn","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2020.173035_bb0135","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s00018-003-3269-3","article-title":"Caffeine as a psychomotor stimulant: mechanism of action","volume":"61","author":"Fisone","year":"2004","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.pbb.2020.173035_bb0140","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0031-6997(24)01396-6","article-title":"Actions of caffeine in the brain with special reference to factors that contribute to its widespread use","volume":"51","author":"Fredholm","year":"1999","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.pbb.2020.173035_bb0145","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s11940-009-0022-8","article-title":"Fatigue in Parkinson\u2019s disease patients","volume":"11","author":"Friedman","year":"2009","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.pbb.2020.173035_bb5000","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0091-3057(94)90115-5","article-title":"D1 and D2 dopamine receptor antagonists block caffeine-induced stimulation of locomotor activity in rats","volume":"47","author":"Garrett","year":"1994","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2020.173035_bb0150","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.pnpbp.2010.08.003","article-title":"Synergism of theophylline and anticholinergics to inhibit haloperidol-induced catalepsy: a potential treatment for extrapyramidal syndromes","volume":"34","author":"Gonz\u00e1lez-Lugo","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2020.173035_bb5010","first-page":"64","article-title":"Biochemical and anatomical substrates of depression and sickness behavior","volume":"47","author":"Hanff","year":"2010","journal-title":"Isr. J. Psychiatry Relat. Sci."},{"key":"10.1016\/j.pbb.2020.173035_bb0155","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0014-2999(97)00040-X","article-title":"Motor depressant effects mediated by dopamine D2 and adenosine A2A receptors in the nucleus accumbens and the caudate-putamen","volume":"323","author":"Hauber","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2020.173035_bb0160","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1097\/00001756-199806010-00024","article-title":"Motor effects induced by a blockade of adenosine A2A receptors in the caudate-putamen","volume":"9","author":"Hauber","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.pbb.2020.173035_bb0165","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1046\/j.0953-816x.2001.01759.x","article-title":"Catalepsy induced by a blockade of dopamine D1 or D2 receptors was reversed by a concomitant blockade of adenosine A(2A) receptors in the caudate-putamen of rats","volume":"14","author":"Hauber","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pbb.2020.173035_bb0170","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1124\/jpet.108.149617","article-title":"Characterization of the potent and highly selective A2A receptor antagonists preladenant and SCH 412348 in rodent models of movement disorders and depression","volume":"330","author":"Hodgson","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2020.173035_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002130050155","article-title":"Behavioral and physiological effects of xanthines in nonhuman primates","volume":"129","author":"Howell","year":"1997","journal-title":"Psychopharmacology."},{"key":"10.1016\/j.pbb.2020.173035_bb0180","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.pbb.2004.12.006","article-title":"Validation of the tremulous jaw movement model for assessment of the motor effects of typical and atypical antipychotics: effects of pimozide (Orap) in rats","volume":"80","author":"Ishiwari","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2020.173035_bb0185","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.bbr.2006.12.020","article-title":"Injections of the selective adenosine A2A antagonist MSX-3 into the nucleus accumbens core attenuate the locomotor suppression induced by haloperidol in rats","volume":"178","author":"Ishiwari","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2020.173035_bb0190","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/syn.20099","article-title":"First visualization of adenosine A(2A) receptors in the human brain by positron emission tomography with [11C]TMSX","volume":"55","author":"Ishiwata","year":"2005","journal-title":"Synapse"},{"key":"10.1016\/j.pbb.2020.173035_bb0195","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.parkreldis.2008.12.006","article-title":"Adenosine, adenosine A2A antagonists, and Parkinson\u2019s disease","volume":"15","author":"Jenner","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.pbb.2020.173035_bb5015","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1523\/JNEUROSCI.11-12-03822.1991","article-title":"Vacuous jaw movements and feeding deficits in rats with ventrolateral striatal dopamine depletion: possible relation to parkinsonian symptoms","volume":"11","author":"Jicha","year":"1991","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2020.173035_bb0200","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/sj.npp.1300167","article-title":"Involvement of adenosine A1 and A2A receptors in the motor effects of caffeine after its acute and chronic administration","volume":"28","author":"Karcz-Kubicha","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2020.173035_bb0205","series-title":"Design and Analysis: A researcher\u2019s Handbook","author":"Keppel","year":"1991"},{"key":"10.1016\/j.pbb.2020.173035_bb0210","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1212\/WNL.52.9.1916","article-title":"Theophylline increases \u201con\u201d time in advanced parkinsonian patients","volume":"52","author":"Kostic","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.pbb.2020.173035_bb0215","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00002826-200201000-00005","article-title":"A double-blind crossover, placebo-controlled study of the adenosine A2A antagonist theophylline in Parkinson\u2019s disease","volume":"25","author":"Kulisevsky","year":"2002","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.pbb.2020.173035_bb0220","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fnbeh.2016.00123","article-title":"Subthalamic and cortical local field potentials associated with pilocarpine-induced oral tremor in the rat","volume":"10","author":"Long","year":"2016","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.pbb.2020.173035_bb0225","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.bbr.2014.05.020","article-title":"Differences between the nonselective adenosine receptor antagonists caffeine and theophylline in motor and mood effects: studies using medium to high doses in animal models","volume":"270","author":"L\u00f3pez-Cruz","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2020.173035_bb0230","doi-asserted-by":"crossref","first-page":"A526","DOI":"10.3389\/fphar.2018.00526","article-title":"Caffeine and selective adenosine receptor antagonists as new therapeutic tools for the motivational symptoms of depression","volume":"9","author":"L\u00f3pez-Cruz","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pbb.2020.173035_bb0235","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.neuropharm.2018.01.034","article-title":"Dopamine depletion shifts behavior from activity based reinforcers to more sedentary ones and adenosine receptor antagonism reverses that shift: relation to ventral striatum DARPP32 phosphorylation patterns","volume":"138","author":"L\u00f3pez-Cruz","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2020.173035_bb0240","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.2042-7158.1994.tb03840.x","article-title":"The effect of theophylline on parkinsonian symptoms","volume":"46","author":"Mally","year":"1994","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.pbb.2020.173035_bb0245","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0163-7258(96)00119-2","article-title":"Potential role of adenosine antagonist therapy in pathological tremor disorders","volume":"72","author":"Mally","year":"1996","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.pbb.2020.173035_bb0250","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/978-3-540-89615-9_18","article-title":"Adenosine A2A receptors and Parkinson\u2019s disease","volume":"193","author":"Morelli","year":"2009","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.pbb.2020.173035_bb0255","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.expneurol.2012.05.023","article-title":"Alteration in the progression of dopamine neuron degeneration: may caffeine offer new perspective?","volume":"237","author":"Morelli","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pbb.2020.173035_bb0260","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00213-008-1441-z","article-title":"The adenosine A2A antagonist MSX-3 reverses the effects of the dopamine antagonist haloperidol on effort-related decision making in a T-maze cost\/benefit procedure","volume":"204","author":"Mott","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2020.173035_bb5040","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0091-3057(01)00524-X","article-title":"D1 or D2 antagonism in nucleus accumbens core or dorsomedial shell suppresses lever pressing for food but leads to compensatory increases in chow consumption","volume":"69","author":"Nowend","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2020.173035_bb0265","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.neuroscience.2010.05.068","article-title":"Differential effects of selective adenosine antagonists on the effort-related impairments induced by dopamine D1 and D2 antagonism","volume":"170","author":"Nunes","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2020.173035_bb0270","doi-asserted-by":"crossref","first-page":"19120","DOI":"10.1523\/JNEUROSCI.2730-13.2013","article-title":"Effort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression","volume":"33","author":"Nunes","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2020.173035_bb0275","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.neuropharm.2012.11.029","article-title":"Psychostimulant pharmacological profile of paraxanthine, the main metabolite of caffeine in humans","volume":"67","author":"Orr\u00fa","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2020.173035_bb0280","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/j.neuropharm.2011.12.033","article-title":"Adenosine A2A receptor antagonism and genetic deletion attenuate the effects of dopamine D2 antagonism on effort-based decision making in mice","volume":"62","author":"Pardo","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2020.173035_bb0285","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.bbr.2013.03.035","article-title":"Effect of subtype-selective adenosine receptor antagonists on basal or haloperidol-regulated striatal function: studies of exploratory locomotion and c-Fos immunoreactivity in outbred and A2AR KO mice","volume":"247","author":"Pardo","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2020.173035_bb0290","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1007\/s00213-015-3872-7","article-title":"Selection of sucrose concentration depends on the effort required to obtain it: studies using tetrabenazine, D1, D2, and D3 receptor antagonists","volume":"232","author":"Pardo","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2020.173035_bb0295","first-page":"535","article-title":"Oral theophylline supplementation and high-intensity intermittent exercise","volume":"43","author":"Pigozzi","year":"2003","journal-title":"J. Sports Med. Phys. Fitness"},{"key":"10.1016\/j.pbb.2020.173035_bb0300","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1016\/j.lfs.2005.04.029","article-title":"New therapies for the treatment of Parkinson\u2019s disease: adenosine A2A receptor antagonists","volume":"77","author":"Pinna","year":"2005","journal-title":"Life Sci."},{"key":"10.1016\/j.pbb.2020.173035_bb0305","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.neuroscience.2013.07.008","article-title":"The vesicular monoamine transporter (VMAT-2) inhibitor tetrabenazine induces tremulous jaw movements in rodents: implications for pharmacological models of parkinsonian tremor","volume":"250","author":"Podurgiel","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2020.173035_bb0310","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.pbb.2015.10.008","article-title":"Induction of oral tremor in mice by the acetylcholinesterase inhibitor galantamine: reversal with adenosine A2A antagonism","volume":"140","author":"Podurgiel","year":"2016","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2020.173035_bb0315","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.bbr.2015.11.008","article-title":"The MAO-B inhibitor deprenyl reduces the oral tremor and the dopamine depletion induced by the VMAT-2 inhibitor tetrabenazine","volume":"298","author":"Podurgiel","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2020.173035_bb0320","doi-asserted-by":"crossref","first-page":"S205","DOI":"10.3233\/JAD-2010-091459","article-title":"Effects of caffeine in Parkinson\u2019s disease: from neuroprotection to the management of motor and non-motor symptoms","volume":"20","author":"Prediger","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.pbb.2020.173035_bb0325","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00213-011-2198-3","article-title":"Stimulant effects of adenosine antagonists on operant behavior: differential actions of selective A2A and A1 antagonists","volume":"216","author":"Randall","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2020.173035_bb0330","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.appet.2009.07.018","article-title":"Dopamine\/adenosine interactions involved in effort-related aspects of food motivation","volume":"53","author":"Salamone","year":"2009","journal-title":"Appetite"},{"key":"10.1016\/j.pbb.2020.173035_bb0335","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0301-0082(98)00053-7","article-title":"Tremulous jaw movements in rats: a model of parkinsonian tremor","volume":"56","author":"Salamone","year":"1998","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pbb.2020.173035_bb0340","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00213-001-0994-x","article-title":"Dopamine antagonists alter response allocation but do not suppress appetite for food in rats: contrast between the effects of SKF 83566, raclopride, and fenfluramine on a concurrent choice task","volume":"160","author":"Salamone","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2020.173035_bb5025","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.bbr.2004.05.019","article-title":"Dopamine agonists suppress cholinomimetic-induced tremulous jaw movements in an animal model of Parkinsonism: tremorolytic effects of pergolide, ropinirole and CY 208-243","volume":"156","author":"Salamone","year":"2005","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2020.173035_bb0345","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2174\/157340006776875914","article-title":"Nucleus accumbens dopamine and the forebrain circuitry involved in behavioral activation and effort-related decision making: implications for understanding anergia and psychomotor slowing in depression","volume":"2","author":"Salamone","year":"2006","journal-title":"Curr. Psychiatr. Rev."},{"key":"10.1016\/j.pbb.2020.173035_bb0350","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.2741\/2952","article-title":"Tremorolytic effects of adenosine A2A antagonists: implications for parkinsonism","volume":"13","author":"Salamone","year":"2008","journal-title":"Front. Biosci."},{"key":"10.1016\/j.pbb.2020.173035_bb0355","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1016\/j.parkreldis.2008.04.017","article-title":"Dopamine\/adenosine interactions related to locomotion and tremor in animal models: possible relevance to parkinsonism","volume":"14","author":"Salamone","year":"2008","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.pbb.2020.173035_bb0360","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.bbr.2009.02.021","article-title":"Differential actions of adenosine A1 and A2A antagonists on the effort-related effects of dopamine D2 antagonism","volume":"201","author":"Salamone","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2020.173035_bb5005","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1901\/jeab.2012.97-125","article-title":"The behavioral pharmacology of effort-related choice behavior: dopamine, adenosine and beyond","volume":"97","author":"Salamone","year":"2012","journal-title":"J. Exp. Anal. Behav."},{"key":"10.1016\/j.pbb.2020.173035_bb0365","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.euroneuro.2012.08.004","article-title":"Conditional neural knockout of the adenosine A2A receptor and pharmacological A2A antagonism reduce pilocarpine-induced tremulous jaw movements: studies with a mouse model of parkinsonian tremor","volume":"23","author":"Salamone","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pbb.2020.173035_bb0370","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/brain\/aww050","article-title":"Activational and effort-related aspects of motivation: neural mechanisms and implications for psychopathology","volume":"139","author":"Salamone","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.pbb.2020.173035_bb0375","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1124\/pr.117.015107","article-title":"The psychopharmacology of effort-related decision making: dopamine, adenosine, and insights into the neurochemistry of motivation","volume":"70","author":"Salamone","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.pbb.2020.173035_bb0380","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pbb.2018.04.004","article-title":"Individual differences in the energizing effects of caffeine on effort-based decision-making tests in rats","volume":"169","author":"SanMiguel","year":"2018","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2020.173035_bb0385","doi-asserted-by":"crossref","unstructured":"SanMiguel N, L\u00f3pez-Cruz L, M\u00fcller CE, Salamone JD, Correa M. (2019). Caffeine modulates voluntary alcohol intake in mice depending on the access conditions: adenosine receptor implication and role of individual differences. Pharmacol. Biochem. Behav. 186: 172789. doi.org\/https:\/\/doi.org\/10.1016\/j.pbb.2019.172789.","DOI":"10.1016\/j.pbb.2019.172789"},{"key":"10.1016\/j.pbb.2020.173035_bb0390","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.pbb.2012.06.009","article-title":"The novel adenosine A(2A) antagonist prodrug MSX-4 is effective in animal models related to motivational and motor functions","volume":"102","author":"Santerre","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2020.173035_bb0395","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.pneurobio.2007.05.001","article-title":"Adenosine A2A receptors and basal ganglia physiology","volume":"83","author":"Schiffmann","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pbb.2020.173035_bb0400","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/bs.irn.2017.05.024","article-title":"Depression and anxiety in Parkinson\u2019s disease","volume":"133","author":"Schrag","year":"2017","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.pbb.2020.173035_bb0405","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1212\/WNL.0b013e318263580e","article-title":"Caffeine in Parkinson disease: better for cruise control than snooze patrol?","volume":"79","author":"Schwarzschild","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.pbb.2020.173035_bb0410","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.expneurol.2004.05.027","article-title":"Blockade of adenosine A2A receptors antagonizes parkinsonian tremor in the rat tacrine model by an action on specific striatal regions","volume":"189","author":"Simola","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pbb.2020.173035_bb0415","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jns.2006.05.038","article-title":"Dopamine and adenosine receptor interaction as basis for the treatment of Parkinson\u2019s disease","volume":"248","author":"Simola","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.pbb.2020.173035_bb0420","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0301-0082(99)00011-8","article-title":"Distribution, biochemistry and function of striatal adenosine A2A receptors","volume":"59","author":"Svenningsson","year":"1999","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pbb.2020.173035_bb0425","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1037\/a0028813","article-title":"Effort-based decision-making in major depressive disorder: a translational model of motivational anhedonia","volume":"121","author":"Treadway","year":"2012","journal-title":"J. Abnorm. Psychol."},{"key":"10.1016\/j.pbb.2020.173035_bb0430","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s002130050593","article-title":"Effects of subchronic administration of clozapine, thioridazine and haloperidol on tests related to extrapyramidal motor function in the rat","volume":"137","author":"Trevitt","year":"1998","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.pbb.2020.173035_bb0435","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.pbb.2009.02.001","article-title":"Adenosine antagonists reverse the cataleptic effects of haloperidol: implications for the treatment of Parkinson\u2019s disease","volume":"92","author":"Trevitt","year":"2009","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2020.173035_bb0440","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejphar.2007.03.021","article-title":"Characterization of the antiparkinsonian effects of the new adenosine A2A receptor antagonist ST1535: acute and subchronic studies in rats","volume":"566","author":"Tronci","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2020.173035_bb0445","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.2741\/2995","article-title":"Potential role of adenosine A2A receptors in the treatment of schizophrenia","volume":"13","author":"Wardas","year":"2008","journal-title":"Front. Biosci."},{"key":"10.1016\/j.pbb.2020.173035_bb0450","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/syn.1070","article-title":"SCH 58261, an A2A adenosine receptor antagonist, counteracts parkinsonian-like muscle rigidity in rats","volume":"41","author":"Wardas","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.pbb.2020.173035_bb0455","doi-asserted-by":"crossref","first-page":"4 89","DOI":"10.1007\/s00213-008-1396-0","article-title":"The adenosine A2A antagonist MSX-3 reverses the effort-related effects of dopamine blockade: differential interaction with D1 and D2 family antagonists","volume":"203","author":"Worden","year":"2009","journal-title":"Psychopharmacology."},{"key":"10.1016\/j.pbb.2020.173035_bb0460","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.neuroscience.2010.02.020","article-title":"Neuroprotection by caffeine: time course and role of its metabolites in the MPTP model of Parkinson\u2019s disease","volume":"167","author":"Xu","year":"2010","journal-title":"Neuroscience"},{"issue":"7","key":"10.1016\/j.pbb.2020.173035_bb0465","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s00213-014-3766-0","article-title":"The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion","volume":"232","author":"Yohn","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2020.173035_bb0470","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.pbb.2010.09.011","article-title":"Spatiotemporal properties of locomotor activity after administration of central nervous stimulants and sedatives in mice","volume":"97","author":"Zhang","year":"2011","journal-title":"Pharmacol. Biochem. Behav."}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305720303683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305720303683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T09:30:45Z","timestamp":1778664645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305720303683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":101,"alternative-id":["S0091305720303683"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2020.173035","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The non-selective adenosine antagonist theophylline reverses the effects of dopamine antagonism on tremor, motor activity and effort-based decision-making","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2020.173035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"173035"}}